Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma
Introduction: Minimal extrathyroidal extension (mETE) is an adverse feature of papillary thyroid microcarcinoma (PTMC), but its preoperative identification remains challenging.
Objective: To develop and validate a dual-phase contrast-enhanced computed tomography (CT) radiomics model and evaluate the complementary value of clinical factors for predicting mETE in PTMC.
Methods: This retrospective study included 311 patients with pathologically confirmed PTMC, randomly assigned to training (n = 217) and testing (n = 94) cohorts. Radiomics features were extracted from arterial- and venous-phase contrast-enhanced CT images and reduced using correlation analysis and least absolute shrinkage and selection operator logistic regression. Independent clinical and conventional imaging predictors were identified by multivariable logistic regression. Clinical, radiomics, and combined models were evaluated by receiver operating characteristic curve analysis, calibration, decision curve analysis, net reclassification improvement, and integrated discrimination improvement.
Results: Thirty-eight radiomics features were retained. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and ultrasonographic capsular contact status were independent predictors of mETE. In the training cohort, the clinical, radiomics, and combined models achieved areas under the curve (AUCs) of 0.765, 0.916, and 0.923, respectively; corresponding AUCs in the testing cohort were 0.615, 0.822, and 0.825. Both the radiomics and combined models demonstrated significantly better discrimination than the clinical model, whereas their difference was not statistically significant (p = 0.894).
Conclusion: The dual-phase CT radiomics model showed good discrimination for mETE in PTMC. Clinical factors provided complementary information but did not significantly improve discrimination. The radiomics-based model may serve as an auxiliary tool for preoperative risk assessment. However, prospective multicenter studies and independent external validation are warranted to establish its clinical utility.
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi: 10.3322/caac.21834
- Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025;35(8):841-985. doi: 10.1177/10507256251363120
- Wang Z, Ji X, Zhang H, Sun W. Clinical and molecular features of progressive papillary thyroid microcarcinoma. Int J Surg. 2024;110(4):2313-2322. doi: 10.1097/JS9.0000000000001117
- Zhan H, Hong Y, Zhang L, Huang K, Zheng M, Zhang F. Impact of location and size of minimal extrathyroidal extension on lymph node metastasis in papillary thyroid cancer: a retrospective analysis. Gland Surg. 2024;13(9):1619-1627. doi: 10.21037/gs-24-273
- Seifert R, Schäfers M, Heitplatz B, Kerschke L, Riemann B, Noto B. Minimal extrathyroidal extension in papillary thyroid microcarcinoma is an independent risk factor for relapse through lymph node and distant metastases. J Nucl Med. 2021;62(12):1702-1709. doi: 10.2967/jnumed.121.261898
- Marongiu A, Nuvoli S, De Vito A, Vargiu S, Spanu A, Madeddu G. Minimal extrathyroid extension (mETE) as the only risk factor in patients with papillary thyroid carcinoma (PC): its clinical impact on recurrence and outcome during long-term follow-up. Biomedicines. 2024;12(2):350. doi: 10.3390/biomedicines12020350
- Guo H, Yang H, Yang Z, Zhu M. The impact of minimal extrathyroidal extension on survival outcomes in patients with pT1 and pT2 differentiated thyroid cancer. Surgery. 2026;190:109820. doi: 10.1016/j.surg.2025.109820
- Song RY, Kim HS, Kang KH. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients. World J Surg Oncol. 2022;20(1). doi: 10.1186/s12957-022-02629-8
- Zuhur SS, Aggul H, Avci U, et al. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study. Endocrine. 2023;83(3):700-707. doi: 10.1007/s12020-023-03533-1
- Li G, Li R, Zhong J, et al. A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma. Nat Commun. 2025;16(1). doi: 10.1038/s41467-025-57627-7
- Issa PP, Albuck AL, Hossam E, et al. The diagnostic performance of ultrasonography in the evaluation of extrathyroidal extension in papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Mol Sci. 2022;24(1):371. doi: 10.3390/ijms24010371
- Lee DY, Kwon TK, Sung MW, Kim KH, Hah JH. Prediction of extrathyroidal extension using ultrasonography and computed tomography. Int J Endocrinol. 2014;2014:351058. doi: 10.1155/2014/351058
- Limkin EJ, Sun R, Dercle L, et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol. 2017;28(6):1191-1206. doi: 10.1093/annonc/mdx034
- Liu Y, Xiang L, Liu FY, et al. Accuracy of radiomics in the identification of extrathyroidal extension and BRAFV600E mutations in papillary thyroid carcinoma: a systematic review and meta-analysis. Acad Radiol. 2025;32(3):1385-1397. doi: 10.1016/j.acra.2024.11.014
- Chen B, Zhong L, Dong D, et al. Computed tomography radiomic nomogram for preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma. Front Oncol. 2019;9:829. doi: 10.3389/fonc.2019.00829
- Yu P, Wu X, Li J, et al. Extrathyroidal extension prediction of papillary thyroid cancer with computed tomography based radiomics nomogram: a multicenter study. Front Endocrinol (Lausanne). 2022;13:874396. doi: 10.3389/fendo.2022.874396
- Feng JW, Zhang L, Yang YX, et al. Development and validation of the multidimensional machine learning model for preoperative risk stratification in papillary thyroid carcinoma: a multicenter, retrospective cohort study. Cancer Imaging. 2025;25(1). doi: 10.1186/s40644-025-00921-w
- Qi Q, Huang X, Zhang Y, et al. Ultrasound image-based deep learning to assist in diagnosing gross extrathyroidal extension thyroid cancer: a retrospective multicenter study. eClinicalMedicine. 2023;58:101905. doi: 10.1016/j.eclinm.2023.101905
- Han ZJ, Shu YY, Lai XF, Chen WH. Value of computed tomography in determining the nature of papillary thyroid microcarcinomas: evaluation of the computed tomographic characteristics. Clin Imaging. 2013;37(4):664-668. doi: 10.1016/j.clinimag.2012.12.005
- Parvathareddy SK, Siraj AK, Qadri Z, et al. Microscopic extrathyroidal extension results in increased rate of tumor recurrence and is an independent predictor of patient’s outcome in Middle Eastern papillary thyroid carcinoma. Front Oncol. 2021;11:724432. doi: 10.3389/fonc.2021.724432
- Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2021;19(2):132-146. doi: 10.1038/s41571-021-00560-7
- Lu WJ, Mao L, Li J, et al. Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer. Front Oncol. 2023;13:1046951. doi: 10.3389/fonc.2023.1046951
- Aerts HJWL, Velazquez ER, Leijenaar RTH, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(1):4006. doi: 10.1038/ncomms5006
- Zhou TH, Zhou XX, et al. CT whole lung radiomic nomogram: a potential biomarker for lung function evaluation and identification of COPD. Mil Med Res. 2024;11(1). doi: 10.1186/s40779-024-00516-9
- Zeng D, Song Z, Liu Q, Huang J, Wang X, Tang Z. Radiomics analysis of dual-layer detector spectral CT-derived iodine maps for predicting Ki-67 PI in pancreatic ductal adenocarcinoma. BMC Med Imaging. 2025;25(1). doi: 10.1186/s12880-025-01664-7
- Tian BW, Yang YF, Yang CC, et al. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy. 2022;14(18):1481-1496. doi: 10.2217/imt-2022-0133
- Kou J, Huang J, Li J, Wu Z, Ni L. Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta-analysis. Clin Exp Med. 2023;23(7):3895-3905. doi: 10.1007/s10238-023-01035-y
- Modestino L, Cristinziano L, Poto R, et al. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer. Front Immunol. 2023;14:1167404. doi: 10.3389/fimmu.2023.1167404
